Phcoker
Xuchang shangke Chemical Co., Ltd
www.phcoker.com
J-147 Overview J-147 powder came into being in 2011 at the Cellular Neurobiology Laboratory of the Salk Institute. Since its inception, there have been numerous studies that affirmed its efficiency in treating Alzheimer’s disease and reversing the aging process. Dr. Dave Schubert with his fellow researchers at the Salk Institute have played significant roles in the study of J-147 curcumin. In 2018, the neurobiologists unraveled the J-147 mechanism of action of the nootropic and its role in managing neurodegenerative diseases. The study and research of this drug are centered on its significance in the management of Alzheimer’s condition. However, healthy users have been interested in the J-147 benefits such as memory enhancement, boosting the learning capacity, and rejuvenation of the neurons. In 2019, pharmacists set out to experiment with the J-147 Alzheimer’s antidote on humans.
Standard Dose of J-147 (1)Regular dose
1
Email: info@phcoker.com